Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    atach-ii
Previous Study | Return to List | Next Study

Antihypertensive Treatment of Acute Cerebral Hemorrhage-II (ATACH-II)

This study has been terminated.
(Planned interim analysis: no significant outcome differences between groups)
Sponsor:
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Medical University of South Carolina
Johns Hopkins University
University of Michigan
Neurocritical Care Research Network
National Cerebral and Cardiovascular Center
Japan Cardiovascular Research Foundation
Beijing Tiantan Hospital
China Medical University Hospital
University Hospital Heidelberg
Seoul National University Hospital
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT01176565
First received: August 4, 2010
Last updated: September 30, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):